Skip to main content

For Healthcare Professionals

Treatment Centers

Treatment Img Mob

TREATMENT CENTERS

QUALIFIED TREATMENT CENTERS (QTCs)*

 

Early referral to a QTC is critical to confirm patient eligibility and initiate treatment

To ensure consistency and quality of treatment, LENMELDY is available at QTCs with experience in HSC transplantation and the management of leukodystrophies. QTCs have the required infrastructure, procedures, and accreditations in place:
  • Appropriate for autologous donations from pediatric patients
  • Collection of HSCs via apheresis or bone marrow harvest
Usmap Otcs Update 1 5 Only

Roll your cursor over the numbers on the map to find the corresponding QTCs listed below.

  1. Benioff Children’s Hospital at University of California at San Francisco (UCSF), San Francisco, CA
  2. University of Minnesota Fairview (UMN), Minneapolis, MN
  3. Children’s Hospital of Philadelphia (CHOP), Philadelphia, PA
  4. Children’s Healthcare of Atlanta (CHOA), Atlanta, GA
  5. Texas Children’s Hospital, Baylor University, Houston, TX
* UMN, CHOP, CHOA, Texas Children’s Hospital, Baylor University, and Benioff Children’s Hospital at UCSF are QTCs.
  • QTCs are independently owned and operated. Orchard Therapeutics does not have oversight over any QTC or the medical care they provide. Contact the QTC or Orchard Assist for additional information
  • Inclusion of a QTC on this map does not represent an endorsement, referral, or recommendation from Orchard Therapeutics. It is the sole discretion of patients and their healthcare professional to determine which QTC may be the best fit for them
  • Please note that the circumstances of coverage may vary based on the QTC. An Orchard Assist representative may be able to provide information about insurance coverage
Orchard Assist can help you connect to one of our trusted and
supported QTCs as soon as possible, so therapy can begin
Orchard Assist can help you connect to one of our trusted and supported QTCs as soon as possible, so therapy can begin
 
Contact your Advanced Therapeutic Account Manager to discuss how Orchard Assist can help your patients:

Email MLDinformation@orchard-tx.com or visit OrchardAssist.com

HSC, hematopoietic stem cell.

IMPORTANT SAFETY INFORMATION

WARNINGS AND PRECAUTIONS

• Thrombosis and Thromboembolic Events:

Treatment with LENMELDY may increase the risk of thrombosis and thromboembolic events.

INDICATION

LENMELDY™ (atidarsagene autotemcel) is an autologous hematopoietic stem cell-based gene therapy indicated for the treatment of children with pre-symptomatic late infantile (PSLI), pre-symptomatic early juvenile (PSEJ), or early symptomatic early juvenile (ESEJ) metachromatic leukodystrophy (MLD).

+